Literature DB >> 15224808

Proximal tubular dysfunction in primary Sjögren's syndrome: a clinicopathological study of 2 cases.

F Bridoux1, X Kyndt, R Abou-Ayache, B Mougenot, S Baillet, M Bauwens, V Lemaitre, J M Goujon, G Touchard, P Vanhille.   

Abstract

Tubulointerstitial nephritis is the most common renal complication in primary Sjögren's syndrome (SS). It is usually associated with symptoms of distal tubular dysfunction, type I (distal) renal tubular acidosis (RTA) and nephrogenic diabetes insipidus. Proximal tubular abnormalities are considered to be less frequent, and Fanconi's syndrome has been only exceptionally reported in patients with SS. We describe 2 patients with primary SS, characterized by xerostomia, dry eyes, extensive lymphocytic infiltrate on salivary gland biopsy, positive tests for anti-SSA/SSB antibodies and/or antinuclear antibodies, who presented in renal failure with proteinuria, microscopic hematuria and type I RTA. Further studies revealed proximal tubular dysfunction, including renal glucosuria, generalized aminoaciduria, phosphaturia, uricosuria, together with proximal (type II) RTA in 1 case. Neither of these patients had Bence Jones proteinuria or monoclonal gammopathy. Kidney biopsy showed focal proximal tubulitis, associated with proximal tubular cell atrophy and dedifferentiation, and diffuse interstitial nephritis with fibrosis. No significant glomerular or peritubular deposits of immunoglobulin light or heavy chain were observed. These findings demonstrate that diffuse, distal and proximal, tubular dysfunction may occur in patients with SS and interstitial nephritis. Lymphocytic infiltration of proximal tubular cells is probably involved in the pathogenesis of Fanconi's syndrome in SS. However, the mechanisms involved in the alteration of sodium-dependent apical transports remain to be elucidated.

Entities:  

Mesh:

Year:  2004        PMID: 15224808     DOI: 10.5414/cnp61434

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

1.  Acquired hypophosphatemia osteomalacia associated with Fanconi's syndrome in Sjögren's syndrome.

Authors:  Yi-Sun Yang; Chiung-Huei Peng; Sung-Kien Sia; Chien-Ning Huang
Journal:  Rheumatol Int       Date:  2006-11-09       Impact factor: 2.631

2.  Multiple bone fracture due to Fanconi's syndrome in primary Sjögren's syndrome complicated with organizing pneumonia.

Authors:  Hideki Nakamura; Junko Kita; Atsushi Kawakami; Satoshi Yamasaki; Hiroaki Ida; Noriho Sakamoto; Akira Furusu; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 3.  Renal involvement in primary Sjögren syndrome.

Authors:  Hélène François; Xavier Mariette
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

4.  Metabolic bone disease as a presenting manifestation of primary Sjögren's syndrome: Three cases and review of literature.

Authors:  Deepak Khandelwal; Saptarshi Bhattacharya; Ankur Gadodia; Rajesh Khadgawat; Nikhil Tandon; A C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2011-10

5.  Sjögren's, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series.

Authors:  Pulukool Sandhya; Debashish Danda; Simon Rajaratnam; Nihal Thomas
Journal:  Open Rheumatol J       Date:  2014-12-19

Review 6.  Sjögren's syndrome complicated with Fanconi syndrome and Hashimoto's thyroiditis: Case report and literature review.

Authors:  Mingmin Shi; Lei Chen
Journal:  J Int Med Res       Date:  2016-03-09       Impact factor: 1.671

7.  Ectopic germinal center and megalin defect in primary Sjogren syndrome with renal Fanconi syndrome.

Authors:  Jing Wang; Yubing Wen; Mengyu Zhou; Xiaoxiao Shi; Lanping Jiang; Mingxi Li; Yang Yu; Xuemei Li; Xuewang Li; Wen Zhang; Andrew L Lundquist; Limeng Chen
Journal:  Arthritis Res Ther       Date:  2017-06-02       Impact factor: 5.156

8.  Adult-onset hypophosphatemic osteomalacia associated with Sjogren syndrome: Clinical case report.

Authors:  Guohua Shen; Yuwei Zhang; Shuang Hu; Bin Liu; Anren Kuang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.